KAS
PPH icon

Kestra Advisory Services’s VanEck Pharmaceutical ETF PPH Stock Holding History

Kestra Advisory Services’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$389K Sell
3,559
-1,314
-27% -$136K ﹤0.01% 2541
2026
Q1 		$506K Buy
4,873
+2,724
+127% +$290K ﹤0.01% 2211
2025
Q4 		$222K Buy
+2,149
New +$209K ﹤0.01% 2800

Other funds holding PPH

AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return
RBC
Rye Brook Capital Greenwich, Connecticut $143M AUM 33.65% 1-Year Est. Return
WWM
WT Wealth Management Scottsdale, Arizona $361M AUM 23.03% 1-Year Est. Return
FF
Fluent Financial Dallas, Texas $280M AUM 16.1% 1-Year Est. Return
AWMT
AAFMAA Wealth Management & Trust Fayetteville, North Carolina $286M AUM 19.57% 1-Year Est. Return
CWRP
Cassady Wealth & Retirement Planning Henderson, Nevada $215M AUM
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AWA
ARQ Wealth Advisors Scottsdale, Arizona $807M AUM 19.58% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $6.28B AUM 24.26% 1-Year Est. Return

Kestra Advisory Services's PPH Position: Q2 2026 in Review

Kestra Advisory Services reduced its VanEck Pharmaceutical ETF (PPH) stake by 27% in Q2 2026, selling an estimated $136K and leaving 3,559 shares worth $389K. The position accounts for ﹤0.01% of the portfolio, ranked #2541.

Kestra Advisory Services first reported a position in PPH in Q4 2025 and has held it in 3 quarters since. The position peaked at $506K in Q1 2026. 40 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Kestra Advisory Services held 3,559 shares of VanEck Pharmaceutical ETF worth $389K as of Q2 2026.
  • Kestra Advisory Services sold 1,314 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $136K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #2541 holding.
  • Kestra Advisory Services first reported a position in VanEck Pharmaceutical ETF in Q4 2025 and has held it in 3 quarters since.
  • Kestra Advisory Services's VanEck Pharmaceutical ETF position peaked at $506K in Q1 2026.
  • 40 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.